Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Pfizer Launches First-of-its-kind ABRYSVO™ Vaccine for Prevention of Respiratory Syncytial Virus in Pregnant Individuals

Pfizer has introduced the first and only ABRYSVO™ vaccine designed to combat lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth to six months. 

ABRYSVO stands out to be a unique vaccine composed of two preF proteins meticulously selected to optimise protection against both RSV A and B strains, and it has shown a strong track record of safety and efficacy.

This groundbreaking vaccine is administered through active immunisation of pregnant individuals during the gestational period of 32 through 36 weeks.

The approval of ABRYSVO as the sole maternal immunisation to safeguard newborns immediately from birth up to six months against RSV is a momentous achievement for public health.

RSV is a highly contagious virus that poses a significant global threat as a common cause of respiratory illnesses. This virus can severely impact the respiratory system of infected individuals, potentially leading to life-threatening conditions.

In the United States alone, there are approximately 500,000 to 600,000 cases of LRTD attributed to RSV each year, making it a leading cause of hospitalisations among children under one year of age.

Recognising the exceptional potential of ABRYSVO, the U.S. Food and Drug Administration (FDA) has granted it breakthrough therapy designation for the prevention of RSV-associated lower respiratory tract illnesses in infants from birth up to six months of age through active immunisation of pregnant women.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024